MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AFTER CYSTOLITHOTRIPSY | ||
| Zagazig University Medical Journal | ||
| Article 10, Volume 24, Issue 4, July 2018, Pages 354-358 PDF (718.71 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/zumj.2018.13237 | ||
| Authors | ||
| Mohammed Alaa Aden Mohammed; Ahmed Ragab Ali; Mohammed Mahmoud Seleem; Abraheem Mohammed Ali | ||
| Abstract | ||
| Background: Benign prostatic hyperplasia (BPH) is a noncancerous increase of the size of the prostate gland. The two main medication classes for BPH management are alpha blockers and 5α -reductase inhibitors .Urinary bladder stones account for 5% of all urinary stone disease. Lithotripsy with the holmium: YAG laser started with making small perforations on the stone surface. the laser fiber should be moved over the surface of the stone vaporizing the stone rather than fragmenting it till fragments become small enough to pass spontaneously or can be safely retrieved. The aim: This study was conducted to investigate the outcomes of Cystolithotripsy with medical Treatment for Benign Prostatic Hyperplasia as an option for treatment of Patients with Bladder Stone and Benign Prostatic Hyperplasia. Methods: prospective short term cohort study. 44 Patients with urinary bladder stone and benign prostatic hyperplasia BPH who are programmed for endoscopic removal of bladder stone with subsequent medical management of BPH, including alpha-blocker (Silodosin 8mg).from January 2017 – June 2017. All laboratory investigation within normal level no renal Hydronephrosis detected by radiological imaging and no malignancy in urinary bladder. Results: In our study shows significant improvement in IPSS which started 17.89±2.35 preoperative to 8.48±0.84 after six months, also significant improvement in PVR which started 90.62±.13.30 Before operation to become 27.27±14.3 After operation and lastly significant improvement in Q-max which started 11.93±1.64 Before operation to become 16.46±0.77 after six month. Conclusion: Medical treatment of benign prostatic hyperplasia after endoscopic removal of bladder stone is an appropriate option for managing patients with bladder stone and benign prostatic hyperplasia. Lithotripsy with Holmium: YAG laser is an appropriate line in management of bladder stone associated with Benign prostatic hyperplasia. | ||
| Keywords | ||
| Background: Benign prostatic hyperplasia (BPH) is a noncancerous increase of the size of the prostate gland. The two main medication classes for BPH management are alpha blockers and 5α -reductase inhibitors .Urinary bladder stones account for 5% of; including alpha-blocker (Silodosin 8mg).from January 2017 – June 2017. All laboratory investigation within normal level no renal Hydronephrosis detected by radiological imaging and no malignancy in urinary bladder. Results: In our study shows signi; also significant improvement in PVR which started 90.62±.13.30 Before operation to become 27.27±14.3 After operation and lastly significant improvement in Q-max which started 11.93±1.64 Before operation to become 16.46±0.77 after six month. Concl | ||
|
Statistics Article View: 377 PDF Download: 416 |
||
